Physician

Ahmed Zakari, MD

According to 2025 Medicare claims, Ahmed Zakari, MD (NPI: 1447268297) practices hematology/oncology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Orange, FL. This provider's primary affiliated billing organization is FLORIDA HOSPITAL MEDICAL GROUP INC (NPI: 1225034234; TIN: 593214635) and primary practice location at 32804-4648.

Zakari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,899 traditional Medicare patients, billed 17,794 HCPCS/CPT codes, and received $246,803 in Medicare payments. The top billing code was 82607 (Cyanocobalamin (vitamin b-12) level). Part D data shows 1,137 prescription claims across 234 beneficiaries totaling $2,079,759 in drug costs, led by Lonsurf (Trifluridine/Tipiracil Hcl). DME data shows 40 claims. Open Payments data shows 131 records totaling $316,872. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $948,602 to $246,803. In contrast, Part D prescription costs have moved sharply higher in recent years, from $1,178,126 to $2,079,759. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $31,096 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	524	96,885	$948,602
2016	503	1,732	$80,854
2017	533	2,101	$72,104
2018	2,356	14,059	$256,074
2019	2,523	16,022	$251,847
2020	2,291	13,214	$196,532
2021	2,535	13,824	$211,201
2022	2,704	14,662	$210,521
2023	1,923	14,903	$220,859
2024	1,899	17,794	$246,803

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	286	1,161	$1,178,126
2016	273	1,015	$502,630
2017	246	825	$152,802
2018	229	772	$143,361
2019	214	709	$118,570
2020	191	700	$139,148
2021	199	876	$467,237
2022	200	944	$701,021
2023	205	835	$503,341
2024	234	1,137	$2,079,759

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	117	448	$87,512
2016	41	152	$27,913
2017	N/R	37	$13,153
2018	N/R	11	$1,284
2019	N/R	26	$3,254
2020	N/R	29	$2,901
2021	N/R	24	$1,161
2022	N/R	50	$1,791
2023	11	60	$22,085
2024	N/R	40	$1,352

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
82607	Cyanocobalamin (vitamin b-12) level	662	1,026	$15
82728	Ferritin (blood protein) level	634	1,066	$13
80053	Blood test, comprehensive group of blood chemicals	1,665	4,110	$10
36415	Insertion of needle into vein for collection of blood sample	733	1,614	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	882	2,410	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lonsurf	Trifluridine/Tipiracil Hcl	32	792	$399,843
Lenvima	Lenvatinib Mesylate	13	390	$296,712
Tasigna	Nilotinib Hcl	12	336	$226,068
Calquence	Acalabrutinib Maleate	14	420	$205,595
Inqovi	Decitabine/Cedazuridine	12	313	$96,009

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	23	$1,033
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	17	$320

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	103	$78,307	Incyte Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	28	$238,565	Adventhealth Orlando
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmed Zakari, MD?

Tedicare shows public-source Medicare data for Ahmed Zakari, MD (NPI 1447268297), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmed Zakari, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ahmed Zakari, MD?

Ahmed Zakari, MD is linked to FLORIDA HOSPITAL MEDICAL GROUP INC (billing NPI 1225034234) in the available physician profile data.

Does Ahmed Zakari, MD have Open Payments data?

Ahmed Zakari, MD has 131 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.